XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.2
SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]        
Total revenues $ 4,839 $ 4,817 $ 9,489 $ 9,524
EBIT 742 711 1,423 1,375
Restructuring costs (29) (19) (68) (31)
Acquisition and disposition-related benefits (charges) 3 2 3 1
Gain (loss) on business and asset dispositions 0 0 0 0
Spin-Off and separation costs (67) (72) (126) (130)
Amortization of acquisition-related intangible assets (35) (32) (66) (63)
Investment revaluation gain (loss) (6) (6) (26) (1)
Interest and other financial charges – net (131) (137) (254) (273)
Non-operating benefit income (costs) 101 123 204 238
Income before income taxes 578 570 1,090 1,116
Operating segments | Imaging        
Segment Reporting Information [Line Items]        
Total revenues 2,596 2,620 5,062 5,116
EBIT 286 278 526 469
Operating segments | Imaging | Radiology        
Segment Reporting Information [Line Items]        
Total revenues 2,171 2,227 4,233 4,315
Operating segments | Imaging | Interventional Guidance        
Segment Reporting Information [Line Items]        
Total revenues 425 393 829 801
Operating segments | Ultrasound        
Segment Reporting Information [Line Items]        
Total revenues 823 839 1,647 1,698
EBIT 178 191 360 398
Operating segments | PCS        
Segment Reporting Information [Line Items]        
Total revenues 772 770 1,519 1,551
EBIT 78 84 159 193
Operating segments | PCS | Monitoring Solutions        
Segment Reporting Information [Line Items]        
Total revenues 538 563 1,065 1,115
Operating segments | PCS | Life Support Solutions        
Segment Reporting Information [Line Items]        
Total revenues 235 207 454 436
Operating segments | PDx        
Segment Reporting Information [Line Items]        
Total revenues 639 568 1,238 1,126
EBIT 200 152 378 307
Other        
Segment Reporting Information [Line Items]        
Total revenues 9 20 24 33
EBIT $ 1 $ 6 $ 1 $ 8